Parking in Midtown Manhattan | NYU Langone Health
NYU Langone offers several convenient parking options for patients and visitors at many of our midtown Manhattan locations.
Parkinson s Foundation PD GENEration Genetic Registry
The Parkinson’s Foundation PDGENEration Genetic Registry study is a prospectiveregistry study of people who are clinically diagnosed with PD. The participants will consist of adult volunteers.
Parkinson’s Disease | NYU Langone Health
Specialists at NYU Langone’s Fresco Institute for Parkinson’s and Movement Disorders offer expert diagnosis and specialized treatment.
Parkinson’s Disease Support | NYU Langone Health
NYU Langone experts provide counseling, support groups, and exercise classes for people with Parkinson’s disease.
Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi- institutional study
Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi- institutional study
Participate in the Cohen Veterans Center Research Study | NYU Langone Health
Complete this form to obtain more information about participating in the Cohen Veterans Center research study.
Partnering with Us During Your Child’s Care | NYU Langone Health
At Hassenfeld Children’s Hospital at NYU Langone, we encourage parents to partner with our care team.
Partners for Youth at Bellevue | NYU Langone Health
NYU Langone’s Partners for Youth at Bellevue provides medical resources for students participating in Public School Athletic League games.
Patella Fractures | NYU Langone Health
NYU Langone orthopedic specialists offer expert diagnosis and treatment, including reconstructive surgery, for patella, or kneecap, fractures.
PATH Inventprise Inc. Phase 1/2 Group B Streptococcus Investigational Vaccine Clinical Trial
The purpose of this study is to gain understanding of the safety, tolerability, and immunogenicity of a new Group B streptococcus (GBS) investigational vaccine (IVT GBS-06) among women of childbearing age. Group B streptococcus (GBS) is a bacterium that can cause severe bacterial infections. About 1 in 5 women carry this bacterium, which can be transferred to their baby, resulting in a life-threatening infection and potentially invasive diseases such as sepsis, pneumonia, and meningitis. It is important to prevent GBS-related infections for those in vulnerable groups, especially among infants born to women carrying this bacterium. There will be 4 study groups. If you are eligible and agree to participate, you will be randomly assigned to 1 of 4 groups: Groups 1, 2, and 3 will receive a single injection of the IVT-GBS 06 investigational vaccine candidate (75% chance) Group 4 will receive the placebo injection (25% chance) If you decide to participate in this study, you would be asked to complete a minimum of 7 in-person study visits over a period of approximately 7 months.